For patients with nonalcoholic fatty liver disease and underlying metabolic disorders, physical activity is associated with a reduction in intrahepatic lipid content and markers of hepatocellular injury.
Duration of estrogen deficiency in women with nonalcoholic fatty liver disease may be more likely to have severe fibrosis.
Researchers found better diagnostic performance for MRI- vs transient elastography-based measurements for liver fibrosis and steatosis.
For obese patients with type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) is associated with an unfavorable metabolic profile.
Patients with moderate to severe fatty liver disease may be more likely to have impaired myocardial perfusion.
Differences in hepatic fat oxidation may explain higher prevalence, risk for nonalcoholic fatty liver disease in men.
Mice study shows alteration in kidney transporter expression, altered metformin pharmacokinetics.
In randomized trial, there was no difference in efficacy of liver fat reduction by aerobic exercise dose or intensity.
Exposure to low doses of hormone-disrupting chemicals may alter the liver genome and function, thereby increasing susceptibility to obesity.
Restricting intake of fructose may prevent accumulation of fat in the liver of obese children.
